Dermatology
Currently, skin conditions are ranked as the 18th leading cause of global disability-adjusted life years (DALYs), which refer to the years lived with disability. Approximately one-fourth of the US population i.e. 84.5 million was affected by skin disease in 2013. Across the 7MM, the population suffering from acne vulgaris and atopic dermatitis stood at 128.9 million and 34.5 million, respectively, in 2017.
Wounds - Pipeline Review, H2 2017
- $2,000
- December 2017
Wounds - Pipeline Review, H2 2017
- Pages: 209
- Published: December 2017
- Report Code: GMDHC9970IDB
- Add to Saved List
Global Markets Direct’s, ‘Wounds - Pipeline Review, H2 2017’, provides an overview of the Wounds pipeline landscape. The report provides comprehensive information on the therapeutics under development for Wounds, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in...
Global Markets Direct’s, ‘Wounds - Pipeline Review, H2 2017’, provides an overview of the Wounds pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Wounds, complete with analysis b...
Bullous Pemphigoid - Pipeline Review, H1 2018
- $2,000
- June 2018
Bullous Pemphigoid - Pipeline Review, H1 2018
- Pages: 66
- Published: June 2018
- Report Code: GMDHC10562IDB
- Add to Saved List
Global Markets Direct’s, ‘Bullous Pemphigoid - Pipeline Review, H1 2018’, provides an overview of the Bullous Pemphigoid pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bullous Pemphigoid, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
Global Markets Direct’s, ‘Bullous Pemphigoid - Pipeline Review, H1 2018’, provides an overview of the Bullous Pemphigoid pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Bullous ...
Pruritus - Pipeline Review, H2 2018
- $2,000
- August 2018
Pruritus - Pipeline Review, H2 2018
- Pages: 139
- Published: August 2018
- Report Code: GMDHC10738IDB
- Add to Saved List
Global Markets Direct’s, ‘Pruritus - Pipeline Review, H2 2018’, provides an overview of the Pruritus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pruritus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players invol...
Global Markets Direct’s, ‘Pruritus - Pipeline Review, H2 2018’, provides an overview of the Pruritus pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Pruritus, complete with anal...